Edward Weinstein is listed as an executive officer and director on 5 SEC Form D filings by 3 issuers between Jul 2017 and Nov 2024: Panome Bio Inc. (Saint Louis, MO — biotechnology — 2023–2024; $6M reported sold to 6 investors), Canopy Biosciences, LLC (Saint Louis, MO — biotechnology — 2017–2018; $2.08M reported sold to 16 investors) and Inflection Point Genetics Inc. (St. Louis, MO — biotechnology — 2022; $265K reported sold to 6 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $8.34M sold in total.
Listed alongside David Smoller (4 shared filings), CRYSTAL WINKELER (2 shared filings), Charles Bolten (2 shared filings), DAVID KINGSLEY (2 shared filings), Deval Lashkari (2 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Edward. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Edward Weinstein and found 3 differences, 1 worth asking the sponsor about: Form D filed 279 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.